Analytical Data
-
Gene name
UNQ1887
- Application
-
Alternative Names
MDHV1887
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q6UWJ2
-
Expression Region
1-384 aa
-
AA Sequence
MAEQTYSWAYSLVDSSQVSTFLISILLIVYGSFRSLNMDFENQDKEKDSNSSSGSFNGNSTNNSIQTIDSTQALFLPIGASVSLLVMFFFFDSVQVVFTICTAVLATIAFAFLLLPMCQYLTRPCSPQNKISFGCCGRFTAAELLSFSLSVMLVLIWVLTGHWLLMDALAMGLCVAMIAFVRLPSLKVSCLLLSGLLIYDVFWVFFSAYIFNSNVMVKVATQPADNPLDVLSRKLHLGPNVGRDVPRLSLPGKLVFPSSTGSHFSMLGIGDIVMPGLLLCFVLRYDNYKKQASGDSCGAPGPANISGRMQKVSYFHCTLIGYFVGLLTATVASRIHRAAQPALLYLVPFTLLPLLTMAYLKGDLRRMWSEPFHSKSSSSRFLEV
-
Molecular Weight
68.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
UNQ1887 is a recombinant protein derived from the expression of a specific gene implicated in various biological processes, including cell signaling and immune response. The research on UNQ1887 focuses on its potential therapeutic applications, particularly in the fields of immunology and oncology. Studies have demonstrated that this protein exhibits significant bioactivity, potentially functioning as a cytokine or growth factor, which may enhance cellular proliferation and modulate immune responses. The background of this research stems from the increasing demand for innovative therapeutic agents that can effectively target and treat complex diseases, such as cancer and autoimmune disorders. Understanding the molecular mechanisms and pathways influenced by UNQ1887 is crucial, as it could lead to the development of novel treatment strategies aimed at improving patient outcomes. Furthermore, ongoing investigations are assessing the safety and efficacy of UNQ1887 in preclinical and clinical settings, with the goal of establishing its role as a valuable component in modern therapeutic regimens. This foundational research aims to bridge the gap between basic science and clinical applications, ultimately contributing to advancements in medical treatment and patient care.
